Stocks
Equillium, Inc.EQ
NASDAQHealthcareBiotechnology$2.47+19.32%
A clinical-stage biotechnology company focused on developing immunology therapies for severe autoimmune and inflammatory diseases. Its pipeline centers on targeting immune pathways such as CD6 to treat conditions including graft-versus-host disease and other immune-mediated disorders. With no approv...
Market Cap: $87.7M52W Range: $0.27 – $2.63
Congressional Interest in Equillium, Inc. (EQ)
6 members of Congress have disclosed 7 trades in Equillium, Inc. (EQ), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 3 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
6
Buys
4
Sells
3
Who in Congress Is Trading EQ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-12-14 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-08-06 | BILLY LONG | sell | $15K – $50K |